The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
13 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $9,841,859 in first-year total cost, median $769,737.
Most frequent study sections
- Special Emphasis Panel[ZAI1 BJM-A (S1)]5
- Special Emphasis Panel[ZAI1 KSW-A (S1)]4
- Special Emphasis Panel[ZAI1 LK-A (S2)]4
Most frequent institutions
- ALBERT EINSTEIN COLLEGE OF MEDICINE1
- BOSTON CHILDREN'S HOSPITAL1
- FLORIDA INTERNATIONAL UNIVERSITY1
- FRED HUTCHINSON CANCER CENTER1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Vectored HIV Immunotherapy via in vivo B cell editing1R01AI174270-01A1 | CURIEL, DAVID TERRYFARZAN, MICHAEL R.MARTINS, MAURICIO DE AGUIAR | WASHINGTON UNIVERSITY, MO | $1,289,517 | ZAI1 |
| 2024 | Eliminating the Immunogenicity of AAV Vectored HIV Antibody Delivery1R01AI174276-01A1 | BALAZS, ALEJANDRO BENJAMIN | MASSACHUSETTS GENERAL HOSPITAL, MA | $822,056 | ZAI1 |
| 2024 | Capsid-engineered AAV vectors with Brec1-based gene therapeutics for inactivating the HIV reservoir1R01AI181053-01 | KUMAR, PRITILANGE, ULRIKE C. | YALE UNIVERSITY, CT | $769,737 | ZAI1 |
| 2024 | Developing and evaluating cell-specific lentivectors capable of selective in vivo generation of anti-HIV T cells to cure HIV1R01AI174275-01A1 | GOLDSTEIN, HARRIS | ALBERT EINSTEIN COLLEGE OF MEDICINE, NY | $734,317 | ZAI1 |
| 2024 | A CRISP(e)R way to silence HIV1R01AI174269-01A1 | UNWALLA, HOSHANG JEHANGIR | FLORIDA INTERNATIONAL UNIVERSITY, FL | $365,159 | ZAI1 |
| 2023 | Lentivirus-like particle specific delivery of Cas12 ribonucleoprotein (RNP) to HIV reservoir cells in vivo for an HIV cure1R01AI174301-01 | HU, WENHUILI, QINGSHENG | TEMPLE UNIV OF THE COMMONWEALTH, PA | $915,099 | ZAI1 |
| 2023 | In vivo transformation of chimeric antigen receptor B cells for a functional cure of HIV1R01AI174277-01 | CHOE, HYERYUNFARZAN, MICHAEL R. | BOSTON CHILDREN'S HOSPITAL, MA | $790,719 | ZAI1 |
| 2023 | Eliminating the latent reservoir by targeted in vivo delivery of HIV-specific CARs1R01AI167061-01A1 | PARHIZ, HAMIDEHRILEY, JAMES L. | UNIVERSITY OF PENNSYLVANIA, PA | $689,181 | ZAI1 |
| 2023 | In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure1R01AI174304-01 | KIEM, HANS-PETERLIEBER, ANDRE MICHAEL | UNIVERSITY OF WASHINGTON, WA | $685,904 | ZAI1 |
| 2022 | Evolving Novel AAV Vectors for Gene Therapy to Cure HIV1R01AI166969-01 | ASOKAN, ARAVINDSACHA, JONAH B. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | $985,350 | ZAI1 |
| 2022 | In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles1R01AI167009-01 | ADAIR, JENNIFER EILEENTAYLOR, JUSTIN J | FRED HUTCHINSON CANCER CENTER, WA | $877,927 | ZAI1 |
| 2022 | In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies1R01AI167003-01 | BARZEL, ADICANNON, PAULA MVOSS, JAMES EVEN | SCRIPPS RESEARCH INSTITUTE, THE, CA | $645,746 | ZAI1 |
| 2022 | In Vivo Gene Editing of B cells with NICE-AAV Vectors1R01AI167004-01 | PETERSON, CHRISTOPHER W | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | $271,147 | ZAI1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.